162 related articles for article (PubMed ID: 10539903)
1. Molecular diagnosis and prognosis in gynecologic oncology.
Silverberg SG
Arch Pathol Lab Med; 1999 Nov; 123(11):1035-40. PubMed ID: 10539903
[TBL] [Abstract][Full Text] [Related]
2. [Molecular diagnostic techniques in gynaecologic cancer].
Salvesen HB; Iversen OE; Tropé C
Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3120-3. PubMed ID: 16299569
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA and gynecologic cancers.
Kanekura K; Nishi H; Isaka K; Kuroda M
J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
[TBL] [Abstract][Full Text] [Related]
4. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
5. What we could do now: molecular pathology of gynaecological cancer.
Herrington CS
Mol Pathol; 2001 Aug; 54(4):222-4. PubMed ID: 11477134
[TBL] [Abstract][Full Text] [Related]
6. Molecular staging of gynecological cancer: What is the future?
Binder PS; Prat J; Mutch DG
Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):776-89. PubMed ID: 25934522
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of gynecologic cancer.
Whang JD; Lee JH
J Korean Med Sci; 1997 Oct; 12(5):383-9. PubMed ID: 9364294
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor markers in gynecological tumors.
Rustin GJ
Curr Opin Oncol; 1996 Sep; 8(5):426-31. PubMed ID: 8914810
[TBL] [Abstract][Full Text] [Related]
9. Office screening for gynecologic cancer.
Zweizig SL
Clin Obstet Gynecol; 1999 Jun; 42(2):267-75. PubMed ID: 10370846
[No Abstract] [Full Text] [Related]
10. Emerging issues of the expression profiling technologies for the study of gynecologic cancer.
Pappa KI; Anagnou NP
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):908-18. PubMed ID: 16157086
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic advances in gynecologic oncology: screening for gynecologic cancer.
Kim YB; Ghosh K; Ainbinder S; Berek JS
Cancer Treat Res; 1998; 95():253-76. PubMed ID: 9619288
[TBL] [Abstract][Full Text] [Related]
12. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
13. The detection of precancerous cervical lesions can be significantly increased.
Marshall Austin R
Arch Pathol Lab Med; 2003 Feb; 127(2):143-5. PubMed ID: 12562226
[No Abstract] [Full Text] [Related]
14. Test detects HPV.
AIDS Patient Care STDS; 1999 Jun; 13(6):377. PubMed ID: 10842865
[No Abstract] [Full Text] [Related]
15. Staging of gynecologic malignancies.
Ascher SM; Takahama J; Jha RC
Top Magn Reson Imaging; 2001 Apr; 12(2):105-29. PubMed ID: 11296804
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus. To screen or not to screen.
Newkirk GR
Arch Fam Med; 1993 Dec; 2(12):1227-8. PubMed ID: 8130902
[No Abstract] [Full Text] [Related]
17. Role of PET in gynecologic malignancy.
Grigsby PW
Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
[TBL] [Abstract][Full Text] [Related]
18. The Current and Future States of Screening in Gynecologic Cancers.
Lee J; Nair N
Obstet Gynecol Clin North Am; 2021 Dec; 48(4):705-722. PubMed ID: 34756291
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus and cervical disease in adolescents.
Guido R
Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening in the early post vaccine era.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
